Computational Redesign and Mechanistic Insights into P450BM3 Enable Regioselective C–H Hydroxylation of Structurally Diverse Steroids

Cytochrome P450BM3 (CYP102A1) is a versatile biocatalyst capable of selective C–H hydroxylation, yet achieving precise regio- and stereoselectivity toward steroid substrates remains challenging. Here, an integrated computational–experimental framework combining Rosetta-based enzyme design, molecular dynamics (MD) simulations, and QM/MM analysis has been developed to rationally reprogram P450BM3 for site-selective steroid hydroxylation. Using LG23 as the parental enzyme, targeted mutations at key sites were introduced to reshape the substrate channel and modulate active-site polarity, improving catalytic activity and selectivity for six structurally diverse substrates, including testosterone (1), nandrolone (2), androstenedione (3), androsta-1,4-diene-3,17-dione (4), 22-hydroxy-23,24-bisnorchol-4-ene-3-one (5), and progesterone (6). The resulting variants, particularly S88T/Q188L and G87A/S88L/W330L, achieved near-quantitative conversions (>95%) and >90% 7β-selectivity toward compact steroids 1–4. For bulky C17-substituted steroids 5 and 6, the L82T/S88L/W330L variant enhanced conversion from <6% to >80% with strict 15β-selectivity. Under optimized biotransformation conditions (20 °C, pH 8.0) with hydroxypropyl-β-cyclodextrin (HP-β-CD), the titer of 7β-hydroxylated 4 reached 645.4 mg/L, which is among the highest reported titers for this transformation to date. Mechanistic analyses revealed that S88 remotely controls regioselectivity via a structurally conserved water-mediated hydrogen-bond network, confirmed by QM/MM calculations, whereas W330L modulates channel gating to accommodate bulky C17 substituents. This work establishes a potentially generalizable paradigm for the rational engineering of regioselectivity in P450 enzymes, enabling high-yield production of hydroxylated steroids and providing transferable design principles for selective C–H hydroxylation of complex steroidal scaffolds.

Authors

Institutions

Publication Details

Journal
ACS Catalysis
Published
2026-01-13
DOI
https://doi.org/10.1021/acscatal.5c08382
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Computational Redesign and Mechanistic Insights into P450BM3 Enable Regioselective C–H Hydroxylation of Structurally Diverse Steroids

Y. Victoria Zhang, Li Zl, Qi Ye, Fuju Wang et al.
ACS Catalysis
Pharmacogenetics and Drug Metabolism
article

Computational Redesign and Mechanistic Insights into P450BM3 Enable Regioselective C–H Hydroxylation of Structurally Diverse Steroids

Y. Victoria Zhang, Li Zl, Qi Ye, Fuju Wang, Hongjia Wei, Ying Cui, Jinghai Zhang, Weizhuo Xu, Fan Zhao
article en

Abstract

Cytochrome P450BM3 (CYP102A1) is a versatile biocatalyst capable of selective C–H hydroxylation, yet achieving precise regio- and stereoselectivity toward steroid substrates remains challenging. Here, an integrated computational–experimental framework combining Rosetta-based enzyme design, molecular dynamics (MD) simulations, and QM/MM analysis has been developed to rationally reprogram P450BM3 for site-selective steroid hydroxylation. Using LG23 as the parental enzyme, targeted mutations at key sites were introduced to reshape the substrate channel and modulate active-site polarity, improving catalytic activity and selectivity for six structurally diverse substrates, including testosterone (1), nandrolone (2), androstenedione (3), androsta-1,4-diene-3,17-dione (4), 22-hydroxy-23,24-bisnorchol-4-ene-3-one (5), and progesterone (6). The resulting variants, particularly S88T/Q188L and G87A/S88L/W330L, achieved near-quantitative conversions (>95%) and >90% 7β-selectivity toward compact steroids 1–4. For bulky C17-substituted steroids 5 and 6, the L82T/S88L/W330L variant enhanced conversion from <6% to >80% with strict 15β-selectivity. Under optimized biotransformation conditions (20 °C, pH 8.0) with hydroxypropyl-β-cyclodextrin (HP-β-CD), the titer of 7β-hydroxylated 4 reached 645.4 mg/L, which is among the highest reported titers for this transformation to date. Mechanistic analyses revealed that S88 remotely controls regioselectivity via a structurally conserved water-mediated hydrogen-bond network, confirmed by QM/MM calculations, whereas W330L modulates channel gating to accommodate bulky C17 substituents. This work establishes a potentially generalizable paradigm for the rational engineering of regioselectivity in P450 enzymes, enabling high-yield production of hydroxylated steroids and providing transferable design principles for selective C–H hydroxylation of complex steroidal scaffolds.

ACS CatalysisVol. 16(3)
Shenyang Pharmaceutical University (CN), Beijing Administration Institute (CN)
Clean water and sanitation
Openalex Percentile: Top 90%
Pharmacogenetics and Drug Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.